Skip to main content
. 2020 Feb 3;22(6):875–885. doi: 10.1093/neuonc/noaa016

Table 5.

Summary of diagnostic performance of urinary biomarkers in differentiating DIPG patients and controls

Biomarker Area Under the Curve (95% CI) Cut-point Based on Youden’s Index Sensitivity Based on Cut-point Specificity Based on Cut-point Accuracy
Netrin-1 0.77 (0.66–0.87) 0.536 98% 49% 76%
bFGF 0.75 (0.64–0.86) 0.419 96% 38% 70%
TIMP-1 0.74 (0.63–0.84) 0.541 100% 8% 58%
MMP-3 0.85 (0.76–0.93) 0.529 78% 81% 79%